Biomatter

BioTech

Seed

Year of investment: 2021

About the company:

Biomatter is a synthetic biology company that creates new proteins for health and sustainable manufacturing applications. The company has developed the Intelligent Architecture™ platform that addresses limitations of current engineering approaches to unlock completely new horizons for protein design and development.

Website: https://biomatter.ai/

Categories: Biotechnology, Life Sciences, Pharmaceuticals

Founded: 2018

Founder(s): Donatas Repečka, Laurynas Karpus, Rolandas Meškys, Vykintas Jauniskis

Location(s): Vilnius, Lithuania

Entry date: 2021

Entry-stage: Seed

Latest stage: Seed

Latest round: Seed

Co-investors: 70Ventures, Business Angels

Exit: n/a

News:

2021: Biomatter Designs raises €500k to develop AI for Generative Protein Design

2024: Biomatter raises a €6.5 million seed round to unlock the power of generative AI for enzyme design

Back to the list